C-reactive protein
C-reactive protein is an intervention with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
NLR AND CRP Useful as Cost-Effective Preliminary Prognostic Markers in ST-Elevation Myocardial Infarction
Evaluation of the Role of Poisoning Severity Score, Serum Procalcitonin and C-reactive Protein in Acute Hydrocarbon Intoxicated Cases Admitted to the Poison Control Center Ain Shams University Hospitals
C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer
Clinical Trials (10)
Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
NLR AND CRP Useful as Cost-Effective Preliminary Prognostic Markers in ST-Elevation Myocardial Infarction
Evaluation of the Role of Poisoning Severity Score, Serum Procalcitonin and C-reactive Protein in Acute Hydrocarbon Intoxicated Cases Admitted to the Poison Control Center Ain Shams University Hospitals
C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer
C-reactive Protein Levels Among Individuals With COVID-19
Post-operative CRP Trend After Ileocolic Resection in Crohn's Disease Patients.
Duration of Antibiotic Therapy in Critically Ill Patients: C-reactive Protein-guided Therapy Versus Best Practice
Malnutrition's Role in Fall Risk
Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker
All 10 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 10